---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-026723"
form_type: "8-K"
ticker: "PLSH"
cik: "0001552189"
company_name: "PANACEA LIFE SCIENCES HOLDINGS, INC."
filed_at: "2021-10-29T23:59:59+00:00"
generated_at: "2026-06-28T16:13:06.674869+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Exactus renamed Panacea Life Sciences; 1-for-28 reverse split; Series C-2 preferred issued to cancel 205M shares

## Summary
- Company changed name to Panacea Life Sciences Holdings, Inc., effective Oct 25, 2021.
- Effected 1-for-28 reverse stock split of common stock.
- Designated 100 shares of Series C-2 Convertible Preferred stock, each convertible into 2,050,000 common shares.
- Issued all 100 Series C-2 shares to Quintel-MC Inc., owned by CEO Leslie Buttorff, in exchange for canceling 205,000,000 common shares.
- CEO Leslie Buttorff is sole owner, officer, and director of Quintel.

## SEC filing metadata
- accession: 0001493152-21-026723
- form_type: 8-K
- ticker: PLSH
- cik: 0001552189
- company_name: PANACEA LIFE SCIENCES HOLDINGS, INC.
- filed_at: 2021-10-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1552189/000149315221026723/0001493152-21-026723-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1552189/000149315221026723/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-026723
- JSON: https://secwatch.observer/filing/0001493152-21-026723.json
- Plain text: https://secwatch.observer/filing/0001493152-21-026723.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.